A naturally inspired industrial biotechnology route to the manufacture of a novel biopolymer with unique properties

一种自然启发的工业生物技术路线，用于制造具有独特性能的新型生物聚合物

• 批准号: 102146
• 金额: $ 38.29万
• 依托单位: INGENZA LIMITED
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2015
• 资助国家: 英国
• 起止时间: 2015 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=102146
• 关键词: naturally; inspired; industrial; biotechnology; route

Synthomer and Ingenza will continue the collaboration begun in a successful TSB co-funded Feasibility Study. Synthomer have identified a market gap for a product which if made using industrial biotechnology would have improved properties and none of the drawbacks of similar materials made by existing manufacturing technologies. They anticipate that this product would be rapidly assimilated into one of their key market areas due the improved characteristics. Synthomer are a top 5 global supplier of emulsion and specialty polymer company with vast experience in this target market. Ingenza are a biotechnology enabler who develop novel bioprocesses using proprietary technologies. Ingenza will develop a bioprocess by creating a GM microorganism capable of manufacturing Synthomer's product. Following the successful completion of the programme, Synthomer and Ingenza expect to enter into a lasting collaboration to optimise a sustainable manufacturing bioprocess for this unique product.

Synthomer和Ingenza将继续在TSB共同资助的可行性研究中开始合作。 Synthomer已经确定了产品的市场差距，如果使用工业生物技术制造的产品将有改善的属性，并且没有现有制造技术制造的类似材料的缺点。他们预计，由于特征的提高，该产品将迅速吸收到其关键市场之一。 Synthomer是乳液和专业聚合物公司的全球前五名供应商，在该目标市场上经验丰富。 Ingenza是一种生物技术推动者，他使用专有技术开发了新型的生物过程。 Ingenza将通过创建能够生产合成器产品的GM微生物来开发生物处理。在该计划成功完成后，Synthomer和Ingenza希望进行持久的合作，以优化该独特产品的可持续制造生物普罗克斯。